Advertisement
Advertisement

ZTS

ZTS logo

ZOETIS INC.

74.16
USD
Sponsored
-1.65
-2.17%
Sep 08, 11:49 UTC -4
Open

ZOETIS INC. Profile

About

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.

Info & Links

CEO

Kristin C. Peck

Headquarters

10 Sylvan Way
Parsippany, NJ 07054, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.zoetis.com

Auditor

KPMG LLP

Share holders

1,356

Employees

14,500

ZOETIS INC. Statistics

Valuation Measures

Market Capitalization2

30.65B

Enterprise Value

38.22B

Enterprise Value/EBITDA(ttm)

9.51

Price to Earnings Ratio(ttm)

11.52

Price to Sales(ttm)

3.29

Price to Book(mrq)

10.10

Price to Cash(ytd)

10.02

Profitability

Gross Margin(ttm)

71.67%

Operating Margin(ttm)

29.73%

Profit Margin(ttm)

27.67%

Return on Equity(ttm)

74.89%

Return on Invested Capital(ttm)

21.35%

Return on Assets(ttm)

18.59%

Income Statement

Revenue(ttm)

9.53B

Revenue Per Share(ttm)

23.05

Gross Profit(ttm)

6.83B

EBITDA(ttm)3

4.02B

Net Income Available to Common(ttm)

2.64B

Diluted EPS(ttm)

6.07

Share Statistics

Beta (5Y Monthly)

0.73

52-Week Change

-51.63%

S&P 500 52-Week Change

19.27%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

413.22M

Dividend Yield

2.80%

Float4

412.31M

% Held by Insiders

0.22%

% Held by Institutions

92.80%

Balance Sheet

Total Cash(mrq)

1.68B

Total Cash Per Share(mrq)

4.06

Total Debt(mrq)

9.05B

Total Debt/Equity(mrq)

287.42%

Current Ratio(mrq)

3.08%

Quick Ratio(mrq)

1.84%

Book Value Per Share(mrq)

7.60

Cash Flow

Operating Cash Flow Per Share(ytd)

2.53

Free Cash Flow(ytd)

840.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement